The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
c-Met: Structure, functions and potential for therapeutic inhibition
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
The Molecular Biology of Axon Guidance
Tessier-Lavigne, M., & Goodman, C. S. (1996) · Science · doi:10.1126/science.274.5290.1123 · Cited by 3,278
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
A genomic view of alternative splicing
Modrek, B., & Lee, C. (2002) · Nature Genetics · doi:10.1038/ng0102-13 · Cited by 1,302
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 1,162
Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G.-L., Song, H.-J., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M.-M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80063-x · Cited by 1,157
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F. (1984) · Nature · doi:10.1038/311029a0 · Cited by 989
Paxillin and focal adhesion signalling
Turner, C. E. (2000) · Nature Cell Biology · doi:10.1038/35046659 · Cited by 839
Homeostatic Regulation of the Immune System by Receptor Tyrosine Kinases of the Tyro 3 Family
Lu, Q., & Lemke, G. (2001) · Science · doi:10.1126/science.1061663 · Cited by 700
Heinrich, M. C., Blanke, C. D., Druker, B. J., & Corless, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1692 · Cited by 634
Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., & Griffin, J. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00069-7 · Cited by 599
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
Birchmeier, C., & Gherardi, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01359-2 · Cited by 597
Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H., & Naoe, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203354 · Cited by 579
Mechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
Ottmann, O. G. (2002) · Blood · doi:10.1182/blood-2001-12-0181 · Cited by 555
Alternative splicing and genome complexity
Brett, D., Pospisil, H., Valcárcel, J., Reich, J., & Bork, P. (2002) · Nature Genetics · doi:10.1038/ng803 · Cited by 536
Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate
Gilmore, A. P., & Burridge, K. (1996) · Nature · doi:10.1038/381531a0 · Cited by 521
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Renzo, M. F. D., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Médico, E., Gaglia, P., Zara, P., & Comoglio, P. M. (1991) · PubMed · Cited by 474
Renzo, M. F. D., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., & Giordano, S. (1995) · PubMed · Cited by 471
The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met
Petrelli, A., Gilestro, G. F., Lanzardo, S., Comoglio, P. M., Migone, N., & Giordano, S. (2002) · Nature · doi:10.1038/416187a · Cited by 471
Peschard, P., Fournier, T. M., Lamorte, L., Naujokas, M. A., Band, H., Langdon, W. Y., & Park, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00378-1 · Cited by 460
Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400812 · Cited by 455
The Semaphorin 4D receptor controls invasive growth by coupling with Met
Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L., & Comoglio, P. M. (2002) · Nature Cell Biology · doi:10.1038/ncb843 · Cited by 444
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Furge, K. A., Zhang, Y.-W., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203859 · Cited by 410
Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., & Salgia, R. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00029-6 · Cited by 391
Self-citationRho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility
Nobes, C. D., & Hall, A. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230456 · Cited by 384
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
Mars, W. M., Zarnegar, R., & Michalopoulos, G. K. (1993) · PubMed · Cited by 373
Turner, C. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4139 · Cited by 363
Signalling by semaphorin receptors: cell guidance and beyond
Tamagnone, L., & Comoglio, P. M. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01816-x · Cited by 354
Wybenga-Groot, L. E., Baskin, B., Ong, S. H., Tong, J., Pawson, T., & Sicheri, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00496-2 · Cited by 338
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
A novel germ line juxtamembrane Met mutation in human gastric cancer
Lee, J.-H., Han, S.-U., Cho, H., Jennings, B., Gerrard, B., Dean, M., Schmidt, L., Zbar, B., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203874 · Cited by 329
Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E. O., Hudson, E. A., Resau, J. H., & Woude, G. F. V. (1997) · PubMed · Cited by 320
Uncoupling of Grb2 from the Met Receptor In Vivo Reveals Complex Roles in Muscle Development
Maina, F., Casagranda, F., Audero, E., Simeone, A., Comoglio, P. M., Klein, R., & Ponzetto, C. (1996) · Cell · doi:10.1016/s0092-8674(00)81372-0 · Cited by 311
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Kelly, L. M., Yu, J.-C., Boulton, C. L., Apatira, M., Li, J., Sullivan, C. M., Williams, I., Amaral, S. M., Curley, D. P., Duclos, N., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00070-3 · Cited by 305
Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
Neckers, L., Schulte, T. W., & Mimnaugh, E. (1999) · Investigational New Drugs · doi:10.1023/a:1006382320697 · Cited by 301
A role for common fragile site induction in amplification of human oncogenes
Hellman, A., Zlotorynski, E., Scherer, S. W., Cheung, J., Vincent, J. B., Smith, D. I., Trakhtenbrot, L., & Kerem, B. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00017-x · Cited by 300
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Molecular Cloning Of Human Paxillin, a Focal Adhesion Protein Phosphorylated by P210BCR/ABL
Salgia, R., Li, J.-L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5039 · Cited by 267
Self-citationCoexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Hepatocyte growth factor, a versatile signal for developing neurons
Maina, F., & Klein, R. (1999) · Nature Neuroscience · doi:10.1038/6310 · Cited by 234
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik, G., Kijima, T., Ma, P. C., Ghosh, S. K., Lin, J. J., Shapiro, G. I., Schaefer, E., Tibaldi, E. V., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 228
Self-citationWang, X., DeFrances, M. C., Dai, Y., Pediaditakis, P., Johnson, C., Bell, A., Michalopoulos, G. K., & Zarnegar, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00439-2 · Cited by 225 · cited 4×
“Efforts in resolving the crystal structure of the c-Met RTK would likely be helpful to allow a starting point in rational design of specific c-Met kinase inhibitors in the future [125].”
BackgroundInfluentialThe mutationally activated Met receptor mediates motility and metastasis
Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., & Vande Woude, G. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14417 · Cited by 224
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
Date, K., Matsumoto, K., Shimura, H., Tanaka, M., & Nakamura, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01475-0 · Cited by 217
Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K., & Herlyn, M. (2001) · Oncogene · doi:10.1038/sj.onc.1205034 · Cited by 212
Overexpression of theMET/HGF receptor in ovarian cancer
Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P., & Comoglio, P. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580507 · Cited by 212
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.325 · Cited by 202
Series Introduction: Invasive growth: from development to metastasis
Comoglio, P. M., & Trusolino, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15392 · Cited by 200
Olivero, M., Rizzo, M., Madeddu, R., Casadio, C., Pennacchietti, S., Nicotra, M., Prat, M., Maggi, G., Arena, N., Natali, P., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.646 · Cited by 199
Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
Roche, J., Boldog, F. L., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B. T., Fishel, R. A., Franklin, W. A., Gemmill, R. M., et al. (1996) · PubMed · Cited by 191
Soman, N. R., Correa, P., Ruiz, B. A., & Wogan, G. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4892 · Cited by 190
Schmidt, L., Junker, K., Weirich, G., Glenn, G., Choyke, P., Lubensky, I., Zhuang, Z., Jeffers, M., Woude, G. V., Neumann, H., et al. (1999) · The Journal of Urology · doi:10.1097/00005392-199905000-00137 · Cited by 189
Series Introduction: Invasive growth: from development to metastasis
Comoglio, P. M., & Trusolino, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215392 · Cited by 174
A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.
Maestrini, E., Tamagnone, L., Longati, P., Cremona, O., Gulisano, M., Bione, S., Tamanini, F., Neel, B. G., Toniolo, D., & Comoglio, P. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.674 · Cited by 170
Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M. K., Sausville, E. A., Monks, A. P., & Woude, G. F. V. (2000) · PubMed · Cited by 168
Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., & Nakamura, T. (2001) · PubMed · Cited by 164
K252a inhibits the oncogenic properties of Met, the HGF receptor
Morotti, A., Mila, S., Accornero, P., Tagliabue, E., & Ponzetto, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205622 · Cited by 158
Takai, K., Hara, J., Matsumoto, K., Hosoi, G., Osugi, Y., Tawa, A., Okada, S., & Nakamura, T. (1997) · Blood · doi:10.1182/blood.v89.5.1560 · Cited by 156
Weimar, I. S., Miranda, N., Muller, E. J., Hekman, A., Kerst, J., GAST, G. C. D., & Gerritsen, W. R. (1998) · PubMed · Cited by 153
HGF: a multifunctional growth factor controlling cell scattering
Stella, M. C. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00089-8 · Cited by 151
Christensen, C., Klingelhöfer, J., Tarabykina, S., Hulgaard, E. F., Kramerov, D. A., & Lukanidin, E. M. (1998) · PubMed · Cited by 146
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
Michieli, P., Basilico, C., Pennacchietti, S., Maffé, A., Tamagnone, L., Giordano, S., Bardelli, A., & Comoglio, P. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202899 · Cited by 140
Organization of the human hepatocyte growth factor-encoding gene
Seid, T., Hagiya, M., Shimonishi, M., Nakamura, T., & Shimizu, S. (1991) · Gene · doi:10.1016/0378-1119(91)90080-u · Cited by 137
Dong, G., Loukinova, E. B., Chen, Z., Gangi, L., Chanturita, T. I., Liu, E. T., & Waes, C. V. (2001) · PubMed · Cited by 136
Müller, M., Morotti, A., & Ponzetto, C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1060-1072.2002 · Cited by 129 · cited 1×
“Activation of NF-kB has been shown to be essential for HGF-mediated proliferation and tubulogenesis in studies characterizing the liverderived MLP29 cell line [66].”
BackgroundSTI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J., O'Dwyer, M. E., Heinrich, M. C., & Druker, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.325 · Cited by 127
Kagoshima, M., Ito, T., & Kitamura, H. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00441.x · Cited by 120
Scatter factors and invasive growth
Comoglio, P. M., & Boccaccio, C. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0366 · Cited by 119
Differential Signaling by the Focal Adhesion Kinase and Cell Adhesion Kinase β
Schaller, M. D., & Sasaki, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25319 · Cited by 118
Horiguchi, N., Takayama, H., Toyoda, M., Otsuka, T., Fukusato, T., Merlino, G. T., Takagi, H., & Mori, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205248 · Cited by 115
Full Activation of the Platelet-derived Growth Factor β-Receptor Kinase Involves Multiple Events
Baxter, R. M., Secrist, J. P., Vaillancourt, R. R., & Kazlauskas, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17050 · Cited by 114
Sattler, M., & Salgia, R. (1998) · Leukemia · doi:10.1038/sj.leu.2401010 · Cited by 109
Self-citationMechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production
Dunsmore, S. E., Rubin, J. S., Kovacs, S. O., Chedid, M., Parks, W. C., & Welgus, H. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24576 · Cited by 109
Porte, H., Triboulet, J. P., Kotelevets, L., Carrat, F., Prevot, S., Nordlinger, B., Gioia, Y. D., Wurtz, A. J., Comoglio, P. M., Gespach, C. P., et al. (1998) · PubMed · Cited by 99
Pathway specificity for Met signalling
Comoglio, P. M. (2001) · Nature Cell Biology · doi:10.1038/35083116 · Cited by 96
Semaphorins as signals for cell repulsion and invasion
Goshima, Y., Ito, T., Sasaki, Y., & Nakamura, F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15467 · Cited by 94
A point mutation in the MET oncogene abrogates metastasis without affecting transformation
Giordano, S., Bardelli, A., Zhen, Z., Ménard, S., Ponzetto, C., & Comoglio, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13868 · Cited by 92
Liu, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00264-9 · Cited by 89
Comoglio, P. M. (1993) · PubMed · Cited by 84
Hayashi, S.-I., Morishita, R., Higaki, J., Aoki, M., Moriguchi, A., Kida, I., Yoshiki, S., Matsumoto, K., Nakamura, T., Kaneda, Y., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0440 · Cited by 81
Vigna, E., Gramaglia, D., Longati, P., Bardelli, A., & Comoglio, P. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202791 · Cited by 81
Semaphorins as signals for cell repulsion and invasion
Goshima, Y., Ito, T., Sasaki, Y., & Nakamura, F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215467 · Cited by 81
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
Zhao, M., Kiyoi, H., Yamamoto, Y., Ito, M. A., Towatari, M., Ōmura, S., Kitamura, T., Ueda, R., Saito, H., & Naoe, T. (2000) · Leukemia · doi:10.1038/sj.leu.2401680 · Cited by 79
Bardelli, A., Basile, M. L., Audero, E., Giordano, S., Wennström, S., Ménard, S., Comoglio, P. M., & Ponzetto, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202607 · Cited by 78
Molecular and cellular biology of small cell lung cancer
Sattler, M., & Salgia, R. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50019 · Cited by 77
Self-citationOsteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Médico, E., Gentile, A., Celso, C. L., Williams, T. A., Gambarotta, G., Trusolino, L., & Comoglio, P. M. (2001) · PubMed · Cited by 75
Mark, M. R., Lokker, N. A., Zioncheck, T. F., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35731-4 · Cited by 74
Parr, C., Hiscox, S., Nakamura, T., Matsumoto, K., & Jiang, W. G. (2000) · International Journal of Cancer · Cited by 73
The HGF receptor family: unconventional signal transducers for invasive cell growth
Comoglio, P. M., & Boccaccio, C. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.37037.x · Cited by 70
Lee, C. C., & Yamada, K. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32190-7 · Cited by 69
Irusta, P. M., & DiMaio, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6912 · Cited by 69
Bardelli, A., Longati, P., Williams, T. A., Benvenuti, S., & Comoglio, P. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29274 · Cited by 68
Lee, C.-C., & Yamada, K. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.507 · Cited by 68
Saucier, C., Papavasiliou, V., Palazzo, A. F., Naujokas, M. A., Kremer, R. B., & Park, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205261 · Cited by 65
Yu, Y., & Merlino, G. T. (2002) · PubMed · Cited by 64
Plexins, Semaphorins, and Scatter Factor Receptors: A Common Root for Cell Guidance Signals?
Artigiani, S., Comoglio, P. M., & Tamagnone, L. (1999) · IUBMB Life · doi:10.1080/152165499306568 · Cited by 62
Comoglio, P. M., Tamagnone, L., & Boccaccio, C. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4684 · Cited by 62
Miller, M., Ginalski, K., Lesyng, B., Nakaigawa, N., Schmidt, L. S., & Zbar, B. (2001) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.1069 · Cited by 62
Derman, M. P., Chen, J. Y., Spokes, K., Songyang, Z., & Cantley, L. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4251 · Cited by 57
Otsuka, T., Jakubczak, J. L., Vieira, W. D., Bottaro, D. P., Breckenridge, D., LaRochelle, W. J., & Merlino, G. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2055-2065.2000 · Cited by 56
Parr, C., Davies, G., Nakamura, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5307 · Cited by 52
Nakashiro, K., Okamoto, M., Hayashi, Y., & Oyasu, R. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64593-2 · Cited by 51
Wojta, J., Nakamura, T., Fabry, A., Hufnagl, P., Beckmann, R., McGrath, K. M., & Binder, B. (1994) · Blood · doi:10.1182/blood.v84.1.151.151 · Cited by 46
Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
Besser, D., Bardelli, A., Didichenko, S. A., Thelen, M., Comoglio, P. M., Ponzetto, C., & Nagamine, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1200879 · Cited by 46
Iwazawa, T., Shiozaki, H., Doki, Y., et al. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03123.x · Cited by 40
Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer
Arteaga, C. L., Khuri, F. R., Krystal, G. W., & Sebti, S. M. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.31524 · Cited by 40
Yi, S., Chen, J. R., Viallet, J., SCHWALL, R. H., Nakamura, T., & Tsao, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.361 · Cited by 34
Soman, N. R., Wogan, G. N., & Rhim, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.738 · Cited by 30
Chan, P.-C., Liang, C.-C., Yu, K.-C., Chang, M.-C., Ho, W. L., Chen, B.-H., & Chen, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204691200 · Cited by 26
Cited by
Cancer metastases: challenges and opportunities
Guan, X. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.005 · Cited by 952
Cui, J. J., Tran-Dubé, M., Shen, H., Nambu, M., Kung, P.-P., Pairish, M., Jia, L., Meng, J., Funk, L., Botrous, I., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007613 · Cited by 932
Self-citationMa, P. C., Jagadeeswaran, R., Jagadeesh, S., Tretiakova, M. S., Nallasura, V., Fox, E. A., Hansen, M., Schaefer, E., Naoki, K., Lader, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2650 · Cited by 576
Self-citationMolecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi, S., & Myers, J. N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700104 · Cited by 516
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
Christensen, J. G., Burrows, J., & Salgia, R. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.044 · Cited by 513
Self-citation
Metadata
- Authors
- Ma, P. C., Maulik, G., Christensen, J., & Salgia, R.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2003-12
- Volume
- 22
- Issue
- 4
- Pages
- 309-325
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1426393029
- Cited by
- 504
- References
- 117
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.